drugset / Trial / NCT05640232
Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study if to evaluate the efficacy and safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea.
Timeline
- Start
- 2025-06-11
- Primary completion
- 2026-06-28
- Completion
- 2027-01-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Buscopan® Composto | Unknown | — | — |
| Subject | CDE100 | Unknown | — | — |